Ductal carcinoma in situ, or DCIS, is the most common kind of non-invasive breast cancer. The number of cases worldwide isn't known, because most international cancer registries don't keep track of DCIS. But in the United States, according to the American Cancer Society, about 60,000 cases of DCIS are diagnosed each year. There are two main reasons this number is so large and has been increasing over time:
It's important to know all the basics, so you can discuss them with your doctor and understand your diagnosis, treatment, and follow-up. You'll want to know:
The name "ductal carcinoma in situ" has three parts:
Women at high risk for DCIS are similar to women at high risk for developing invasive cancers. The shared risk factors include:
DCIS generally has no physical signs or symptoms. A small number of women may have a lump in the breast or some discharge coming out of the nipple.
DCIS is usually found by mammography. As the old cancer cells die off and pile up, tiny specks of calcium (called "calcifications" or "microcalcifications") form within the broken-down cells. The mammogram will show the buildup of cancer cells inside the ducts as a cluster of these microcalcifications or as a shadow or lump.
If you do have a suspicious mammogram, your doctor will probably want you to have a breast biopsy. There are two ways to get a biopsy done with only a little bit of surgery. (More invasive biopsies are rarely needed for DCIS):
These tests are done to establish a diagnosis, not to remove the whole cancerous area. More surgery is needed to remove the whole cancer with clear margins.
DCIS is not life-threatening. It is non-invasive, and is considered the earliest form of cancer—Stage 0. Stage 0 breast cancer (sometimes called pre-cancer) is an uncontrolled growth of breast cells that is stuck inside the milk duct where it started. It has not yet figured out how to spread outside the duct or to other areas of the body.
Although this cancer stays inside the milk ducts, it raises the risk of getting an invasive cancer in the future. About 25% to 50% of women whose DCIS is treated by surgery ONLY (without radiation) eventually develop an invasive cancer. Most of those cancers (recurrences) happen within the first 5 to 10 years after a DCIS diagnosis.
But a new cancer may turn up 25 years later—or longer. This usually happens in the same area of the breast where the DCIS was. The new cancer can be either non-invasive (not life-threatening) or invasive (potentially serious). The main goal of treating DCIS is to reduce the risk of an invasive cancer later on.
In most cases, the treatment for DCIS is breast-conserving surgery (lumpectomy). The DCIS must be removed with clean margins (also called margins of resection). To substantially lower the risk of developing an invasive cancer, most doctors recommend additional treatment with radiation after surgery for DCIS.
Women with hormone-receptor-positive DCIS may choose to receive hormonal therapy after surgery to reduce the risk of recurrence and to lower the risk of getting a new cancer.
Breastcancer.org 7 East Lancaster Avenue, 3rd Floor Ardmore, PA 19003
Learn more about our commitment to your privacy
© 2009 Breastcancer.org - All rights reserved.
Breastcancer.org is a non-profit organization dedicated to providing information and community to those touched by this disease. Learn more about our commitment to providing complete, accurate, and private breast cancer information.